Introduction
Heterotrimeric guanine nucleotide-binding proteins, or G proteins, consisting of a-, b-and g-subunits, transduce signals from heptahelical cell surface receptors to intracellular effectors (Simon et al., 1991; Hepler and Gilman, 1992; Conklin and Bourne, 1993) . The a-subunit is a 37-42 kDa protein, which contains the guanine nucleotide-binding pocket along with the intrinsic GTPase activity. The 35-kDa b-subunit and the 8-11-kDa g-subunit are tightly associated with each other and are often referred to as a single entity, the bg-subunit (Simon et al., 1991; Hepler and Gilman, 1992; Conklin and Bourne, 1993) . To date, 17 different a-subunits, five b-subunits and 12 g-subunits have been identified. However, the amino acid identity of the a-subunits has been used as a basis for the classification of G proteins into G s , G i , G q and G 12 families in which the a-subunits that show more than 50% homology are grouped together (Simon et al., 1991) . In G-protein-coupled receptor (GPCR)-mediated signaling pathways, ligand-activated receptors catalyse the exchange of the bound GDP to GTP in the a-subunit following which the GTP-bound a-subunit disassociate from the receptor as well as the bg-subunit. The GTPbound a-subunit and the bg-subunit stimulate distinct downstream effectors including enzymes, ion channels and small GTPase, thus regulating multiple signaling pathways including those involved in the activation of mitogen-activated protein kinase (MAPK) modules (Johnson and Dhanasekaran, 1989; Hepler and Gilman, 1992; Dhanasekaran et al., 1995; Dhanasekaran and Prasad, 1998; Rozengurt, 1998) .
MAPK modules regulate many critical signaling pathways including cell proliferation, differentiation and apoptosis (Fanger et al., 1997; Minden and Karin, 1997; Dhanasekaran and Premkumar Reddy, 1998; Gutkind, 1998; Garrington and Johnson, 1999; Davis, 2000; Chang and Karin, 2001) . Each of these modules consists of at least three distinct kinases, namely an upstream mitogen-activated protein (MAP) kinase kinase kinase (MAP3K), a MAP kinase kinase (MAP2K) and a downstream MAP kinase (MAPK). In a typical signaling pathway, growth factor stimulated small GTPases such as Ras, CDC42, and Rac activate an upstream MAP kinase kinase kinase kinase (MAP4K), following which the MAP kinase cascades proceed through the sequential phosphorylation of constituent MAP3K, MAP2K and MAPK (Minden and Karin, 1997; Dhanasekaran and Premkumar Reddy, 1998; Davis, 2000; Chang and Karin, 2001) . Activated MAP kinases translocate from the cytosol to the nucleus where they regulate the activities of various transcription factors through phosphorylation (Khokhlatchev et al., 1998; Brunet et al., 1999) . GPCRs, primarily through their cognate G proteins, regulate these three-tier MAPK phospho-relay systems to modulate the expression of specific primary as well as secondary response genes involved in cell proliferation, differentiation and apoptosis (Gutkind, 2000; Kranenburg and Moolenaar, 2001; Werry et al., 2005) . G proteins have been shown to regulate diverse transcription factors such as AP-1 (Araki et al., 1997) , NF-kB, CRE, SRE (Takeuchi and Fukunaga, 2003) , ATF1 (Ghosh et al., 2002) , STAT3 (Sellers et al., 1999) , ELK1 (Todisco et al., 1997) , Egr-1 (Gerasimovskaya et al., 2002) , HIF-1a (Sodhi et al., 2000) , MEF2 (Fukuhara et al., 2000a, b) via ERK-, JNK-, p38MAPKs-or ERK5 modules. However, only recently the dynamic and multilayered mechanisms by which G proteins regulate these MAPK networks have begun to be unraveled. This review is focused on analysing the mechanisms by which G proteins regulate different MAPK networks in a context-specific manner.
Regulation of MAPKs by G s G s , defined by the a-subunit Ga s , transduces signals from G s -coupled heptahelical receptors to adenylyl cyclase that converts ATP to cAMP and subsequently to cAMP-mediated activation of protein kinase A (PKA) (Gilman, 1987; Hepler and Gilman, 1992) . Consequently, as depicted in Figure 1 , cAMP as well as cAMP-activated PKA have been shown to play a major role in Ga s -mediated stimulation as well as inhibition of MAPK modules such as those of ERK1/2, ERK5 and p38MAPK Graves et al., 1993; Wu et al., 1993; Wan and Huang, 1998; Zheng et al., 2000; Laroche-Joubert et al., 2002; Stork and Schmitt, 2002; Dumaz and Marais, 2005; Houslay, 2006; Pearson et al., 2006) .
Ga s stimulation of ERK1/2
The initial evidence that Ga s is involved in the regulation of ERK1/2 signaling module consisting of a MAP3K-MAP2K-MAPK module defined by Raf, MEK1/2 and ERK1/2, respectively, came from studies focused on defining the oncogenic pathways regulated by the gsp oncogene that encodes the constitutively activated mutants of Ga s (Landis et al., 1989; Lyons et al., 1990) . Functional characterization of these activating mutations indicated that the ectopic expression of Ga s could stimulate ERK1/2 in different cell types (Faure et al., 1994) . Using mutant S49 lymphoma cell lines that lack Ga s or PKA, it was further established that Ga s and PKA are required to couple b 2 -AR signaling to ERK1/2 module . Analysis of such Ga s -mediated stimulation of ERK1/2 indicated that it was mediated by a pathway involving Rap-1 and its activation of B-Raf, one of the isoforms of Raf (Vossler et al., 1997; Wan and Huang, 1998; Schmitt and Stork, 2000; Weissman et al., 2002; Dumaz and Marais, 2005; Houslay, 2006; Wang et al., 2006b) . One of the mechanisms through which Ga s activates Rap-1 involves cAMP-mediated direct activation of EPAC (exchange protein directly activated by cAMP), a guanine nucleotide exchange factor (GEF) specific for Rap-1 (de Rooij et al., 1998; Quilliam et al., 2002; Bos, 2006) . In rat kidney cortical collecting duct cells, it has been shown that the stimulation of Ga s and subsequent generation of cAMP leads to the activation of EPAC, which stimulates GDP-GTP exchange in Rap-1. The GTP-bound Rap-1, thus stimulated, activates B-Raf and the downstream ERK1/2 modules (Laroche-Joubert et al., 2002) . The observation that the introduction of antibodies to Epac-1, Rap-1 and B-Raf into these cells inhibited G s -mediated activation of ERK1/2 module established the linear pathway leading from cAMP to the activation of ERK1/2 module involving Epac-1, Rap-1 and B-Raf (Laroche-Joubert et al., 2002) . Although further studies confirmed the role of Rap-1 in Ga s -stimulated activation of ERK1/2 module, they also indicated that Ga s stimulation of ERK1/2 module via Rap-1 involves a Rap-1 GEF other than EPAC in many cell types (Stork and Schmitt, 2002) . The cAMP analog, 8-(4-chloro-phenylthio)-2 0 -O-methyladenosine-3 0 , 5 0 -cyclic monophosphate (8CPT-2Me-cAMP) that can activate EPAC, but not PKA, proved useful in identifying the alternate pathway through which Ga s activated ERK1/2 via Rap-1 (Enserink et al., 2002) . The observations that 8CPT-2Me-cAMP stimulated EPAC but failed to activate Rap-1-dependent activation of ERK suggested that EPAC might not be involved in Rap-1-mediated activation of ERK1/2 module in all the cells (Enserink et al., 2002) . Further studies have indicated that in many cell types, Ga s -mediated activation of ERK1/2 signaling via Rap-1 involves novel Rap-1-GEF known as Crk SH3 domain-binding guanine nucleotide-releasing factor, or C3G (Tanaka et al., 1994; Gotoh et al., 1995) . It should be noted here that unlike the direct activation of EPAC by cAMP (de Rooij et al., 1998; Quilliam et al., 2002; Bos, 2006) , the activation of C3G requires the PKA-mediated phosphorylation of Ser-17 of Src (Schmitt and Stork, 2002a; Obara et al., 2004; Weissman et al., 2002; Wang et al., 2006b) , subsequent Src-mediated activation of Cbl, Cbl-mediated recruitment of Crk-C3G complex and Crk-SH3 domain-mediated recruitment as well as activation of C3G (Ichiba et al., 1999; Stork, 2000, 2002a) . Results from these studies establish a paradigm in which Ga s stimulates ERK1/2 via a pathway involving cAMP-PKA-Src-mediated activation of C3G, C3G stimulation of Rap-1 and, finally, Rap-1-mediated activation of B-Raf-MEK-ERK module (Schmitt and Stork, 2000; Weissman et al., 2002; Obara et al., 2004; Wang et al., 2006b) .
Finally, it has also been noted that Ga s -cAMPmediated activation of Ras is involved in the stimulation of ERK1/2 modules, as demonstrated in cortical neurons (Ambrosini et al., 2000) , thyrocytes (Tsygankova et al., 2000) , melanocytes (Busca et al., 2000) and melanoma cell lines (Busca et al., 2000; Amsen et al., 2006) , in addition to COS-7 as well as HEK293 cells (Norum et al., 2003 (Norum et al., , 2005 . In these cells, Ga s stimulates Ras and the subsequent activation of ERK1/2 modules via PKA-dependent or -independent mechanism in a celltype-specific manner. Thus, Ga s -mediated PKA-dependent stimulation of Ras signaling to ERK1/2 module has been shown to involve a PKA-dependent Ras-GEF known as Ras-GRF1 in COS-7 and HEK293 cells (Norum et al., 2005 (Norum et al., , 2007 , whereas PKA-independent signaling involves a cAMP-responsive but PKA-independent Ras-GEF known as CNrasGEF in melanoma cell lines (Amsen et al., 2006) .
Ga s inhibition of ERK1/2
Ga s -mediated cAMP-PKA signaling pathway has also been shown to potently inhibit ERK pathways Graves et al., 1993; Wu et al., 1993) . A primary mechanism by which Ga s inhibits the ERK pathway involves PKA-mediated phosphorylation of a specific isoform of Raf, known as Raf-1 or C-Raf Dhillon et al., 2002) . C-Raf contains three PKA-target Serines, namely Ser 43, 259 and 621 (Morrison et al., 1993) , all of which can be phosphorylated in vitro by PKA Hafner et al., 1994; Mischak et al., 1996) . Mutational analyses of C-Raf indicated that the Ga s -mediated cAMP-PKA signaling axis inhibits C-Raf through the phosphorylation of Ser-259 (Dhillon et al., 2002) . The PKA phosphorylation of Ser-259 of C-Raf attenuates the phosphorylation of Ser-338, which is involved in the activation of C-Raf (Dhillon et al., 2002) , thus providing a molecular basis for Ga s -mediated inhibition of C-Raf-MEK1/3-ERK1/2 module. In addition, it has been shown that Ga s -cAMP-PKA-mediated activation of Rap-1 is also involved in the inhibition of C-Raf containing ERK module in fibroblast cell lines such as NIH3T3 cells Stork, 2001, 2002b) . This has been primarily attributed to the close sequence and structural similarities of the effector domain of Rap-1 with that of Ras, through which Rap-1 binds and sequesters C-Raf from being activated by Ras (Bos, 1998; Stork, 2001, 2002b) .
In summary, it can be surmised that Ga s stimulates B-Raf-MEK-ERK1/2 module via Rap-1 pathway in cells that express B-Ras. However, Ga s stimulates or inhibits C-Raf-MEK1/2-ERK1/2 modules dependent on the cell type in which C-Raf is expressed. Whereas Ga s -mediated stimulation of C-Raf-MEK1/2-ERK1/2 module involves PKA-dependent or -independent activation of Ras, Ga s -mediated inhibition involves PKA-mediated phosphorylation or Rap-1-mediated sequestration of C-Raf. In light of recent findings that adenylyl cyclase as well as PKA are functionally and/or physically compartmentalized through their interactions with proteins such as ERKs (Gros et al., 2006) or AKAPs (Dumaz and Marais, 2005; Houslay, 2006) , it is quite possible that the Ga s -mediated differential regulation of ERK modules by Ga s involves different pools of adenylyl cyclase and/or PKA in a single cell.
Ga s regulation of p38MAPK and ERK5
In addition to its role in the regulation of ERK1/2 modules, Ga s is involved in the regulation p38MAPK as well as ERK5 modules through the cAMP-PKA signaling axis. In cardiomyocytes, it has been demonstrated that the b2-AR stimulates the activity of p38 MAPK involving the classical Ga s -cAMP-PKA mechanism (Zheng et al., 2000) . Although the mechanism through which Ga s couples to the p38MAPK module is far from clear, the findings that Rap-1 can stimulate p38MAPK in diverse cell types (Ahn et al., 2005 (Ahn et al., , 2006 point to the possible role of Rap-1 in this pathway. However, such a role for Rap-1 in Ga s -mediated activation of p38MAPK remains to be established.
In the case of ERK5, it has been established that the cAMP-PKA pathway is involved in inhibition of the ERK5 module consisting of MEKK2, MEK5 and ERK5 (Pearson et al., 2006) . Interestingly, it has been observed that pretreatment of cells with cAMP inhibited receptor tyrosine kinase (RTK)-mediated activation of ERK5 in HeLa, C2C12 and NIH3T3 cells. Analysis of the underlying mechanism has indicated that PKA phosphorylates MEKK2 at Ser 153, the phosphorylation of which inhibits its coupling to upstream activators, presumably the candidate MAP4Ks. Thus, Ga s -cAMP-PKA-mediated phosphorylation of MEKK2 potentially leads to the overall inhibition of signaling by MEKK2-MEK5-ERK5 module (Pearson et al., 2006) .
Regulation of MAPKs by G i
The G i family of G proteins is defined by the a-subunits Ga i1 , Ga i2 , Ga i3 , Ga z , Ga oA and Ga oB . The identification of the activated mutants of Ga i2 as the gip2 oncogene in pituitary adenomas as well as tumors of the ovary and the adrenal cortex (Lyons et al., 1990) indicated the mitogenic activity of Ga i . Studies focused on defining the molecular basis for such mitogenic activity identified the role of Ga i in the regulation of the ERK module (L'Allemain et al., 1991; Pouyssegur and Seuwen, 1992b) . Expression of the GTPase deficient, constitutively activated mutant of Ga i2 resulted in the oncogenic transformation of Rat1 fibroblasts Gupta et al., 1992b) . Functional characterization of the transformed phenotype indicated that expression of the activated Ga i2 was associated with constitutive activation of p44-ERK activity (Gupta et al., 1992a) . Subsequent studies have shown that Ga i2 can activate the ERK module through a diverse set of mechanisms involving either direct or indirect activation of Ras (Pace et al., 1995; Edamatsu et al., 1998) . In addition to its activation of ERK modules through these mechanisms, Ga i also appears to transmit signals to ERK as well as other MAPK modules via its erstwhile associated bg-subunit (Figure 2 ; Crespo et al., 1994; Faure et al., 1994; Koch et al., 1994; Pace et al., 1995) .
Ga i stimulation of ERK1/2
Ga i -dependent activation of ERK primarily involves the suppression of two inhibitory pathways. One mechanism involves its inhibitory effect on adenylyl cyclase, whereas the other involves its inhibitory effect on Rap-1 via Rap-1-GAP protein. The well-characterized signal transduction role of Ga i is to couple specific receptors to the inhibition of adenylyl cyclase (Johnson and Dhanasekaran, 1989; Tang and Gilman, 1992) . Consistent with this prototypic signaling role of Ga i , expression of gip2, the activated mutant of Ga i , resulted in a decrease in the accumulation of cAMP in cultured cells (Lowndes et al., 1991; Wong et al., 1991) . Such a Ga i -mediated decrease in cAMP levels and subsequent decrease in PKA activity relieves the inhibitory effect of PKA on C-Raf, thus potentiating Ras-C-Raf signaling to ERK module (Radhika and Dhanasekaran, 2001) . The observation that the expression of Ga i2 slightly enhances the activation of C-Raf (Pace et al., 1995) is consistent with this view.
However, Ga i has also been shown to activate the ERK pathway via an alternate Ras-dependent mechanism (Pace et al., 1995; Mochizuki et al., 1999) . Using a strategy wherein the expression of a pertussis toxin-resistant mutant of Ga i2 in cells treated with PTX could be used to monitor the effect of A1-adenosine receptors specifically coupled to the transfected PTXresistant Ga i2 ; it was demonstrated that the expression of Ga i2 and subsequent activation by A1 adenosine receptor led to the stimulation of ERK activity (Pace et al., 1995) . In addition, the coexpression of dominant negative mutant of Ras inhibited Ga i2 -mediated activation of MEK and the downstream ERK, indicating a role for Ras in this pathway (Pace et al., 1995) . However, an intriguing observation was that there was no increase in the GTP-bound active form of Ras upon the stimulation of Ga i2 by A1-adenosine receptors. Thus, although these studies indicated that the activation of ERK by Ga i2 required functional Ras, the molecular basis for such requirement with little or no modulation of the activation Ras was not clear. However, the later observation that Ga i2 can interact with Rap-1-GAP provided a molecular basis for a mechanism in which Ga i2 can activate ERK through a Ras-sensitive pathway without directly activating Ras (Mochizuki et al., 1999) . Rap-1 was initially identified as a Ras-like GTPase that can act as a tumor suppressor by attenuating Ras-mediated cellular transformation (Pizon et al., 1988; Kitayama et al., 1989) . Rap-1-mediated suppression of transformation is associated with the ability of activated Rap-1 to attenuate Ras-dependent ERK activation by EGF as well as LPA . As described earlier, activated Rap-1 through its Ras-homologous effector domain sequesters C-Raf (Bos, 1998; Stork, 2001, 2002b) , thus disrupting Ras-mediated signaling to the C-Raf-MEK-ERK-signaling module. Ga i2 attenuates the Ras-antagonistic inhibitory activity of Rap-1 by recruiting a specific Rap-1 GTPase activating protein II (Rap1GAPII), which can downregulate Rap-1 activity (Mochizuki et al., 1999) . Thus, mutational or receptormediated activation of Ga i2 facilitates the translocation of Rap1GAPII to the plasma membrane where Rap1-GAPII accelerates the GTPase activity of Rap-1, thereby rendering it inactive. Subsequent release of sequestered C-Raf leads to Ras-C-Raf reassociation and the activation of the downstream ERK1/2 module (Mochizuki et al., 1999) . It is significant to note here that the pathway deduced from this signaling paradigm supports a view that Ga i2 stimulates Ras-dependent ERK signaling without directly involving the activation of Ras by inhibiting the activity of Rap-1.
Gbg i stimulation of ERK1/2 G i has also been shown to stimulate the ERK1/2 signaling module by mechanisms that involve the disassociated bg-subunits (Crespo et al., 1994; Koch et al., 1994) . Expressing the bg-subunit interacting COOH domain of the b-adrenergic receptor kinase (bARK-CT) or Ga t , both of which can function as antagonists of bg signaling by virtue of their ability to sequester endogenous bg, it has been demonstrated that the bg-subunit is involved in activation of ERK by a number of G i -coupled receptors including m 2 -muscarcinic, a 2 -adrenergic, D 2 dopamine, A1 adenosine and LPA receptors (Crespo et al., 1994; Koch et al., 1994) . Consistent with these observations, expression of bgsubunit has been shown to increase the basal activity of ERK in COS-7 cell (Faure et al., 1994) . Further analyses using a dominant negative mutant of Ras have indicated that the bg-mediated activation of ERK1/2 module involves Ras (Crespo et al., 1994; Faure et al., 1994; Koch et al., 1994) . Although bg-subunit-mediated activation of ERK module has been shown to involve Ras (Crespo et al., 1994; Koch et al., 1994) , the mechanism through which the bg-subunit couples to Ras appears to be cell-type specific. However, the consensus is that the activation of Ras by bg-subunit involves a tyrosine kinase, the identity of which is context specific. The immediate step involved in bgmediated activation of ERK involves phospholipase-C-b (PLC) and/or phosphoinositide-3-kinase (PI3K), both of which can be activated by the bg-subunit (Camps et al., 1992; Katz et al., 1992; Stephens et al., 1994; Thomason et al., 1994) . Transfection studies using COS-7 or HEK293 cells have established a model in which G i -coupled a 2 A-adrenergic receptors stimulate ERK1/2 modules via the released bg-subunits (Lev et al., 1995; Dikic et al., 1996; Della Rocca et al., 1997) .
In this model, bg-subunit released from G i -heterotrimer stimulates PLCb leading to phosphatidylinositol trisphosphate (IP3)-mediated increase in intracellular Ca 2 þ and Ca 2 þ -calmodulin-mediated activation of Pyk2 kinase. The Pyk2 kinase thus stimulated, activates Src, which in turn stimulates Shc adaptor protein leading to the activation of Ras via the Ras-GEF, mSOS (Lev et al., 1995; Dikic et al., 1996; Luttrell et al., 1996; Della Rocca et al., 1997) .
In some other cellular contexts, it has been observed, bg-subunit transmits signals through an Src-and Shcindependent mechanism involving the phosphorylation of dynamin II and its association with Grb2 (Kranenburg et al., 1997 (Kranenburg et al., , 1999a . In Rat1a and COS-7 cells, it has been demonstrated that LPA-or thrombin receptor stimulated release of bg-subunit activates ERK1/2 module via a pathway involving PI3K and PI3K-mediated activation of a tyrosine kinase that promotes dynamin II-Grb2 complex formation with the resultant activation of Ras and the ERK1/2 module (Kranenburg et al., 1997 (Kranenburg et al., , 1999a . Since dynamin can link Ras-GEF SOS to Ras (Wunderlich et al., 1999) , it is possible that the dynamin facilitates bg-mediated activation of Ras in this complex. As dynamin has been shown to play a critical role in vesicular endocytosis (Hinshaw and Schmid, 1995; Praefcke and McMahon, 2004) , and vesicular endocytosis has been shown to be required for H-Ras-mediated activation of ERK1/2 module (Roy et al., 2002) , it is likely that dynamin II-mediated endocytosis plays a critical role in bg-mediated activation of ERK1/2. As seen in the case of b-arrestinmediated activation of ERK1/2 in endocytic vesicles (Lefkowitz and Shenoy, 2005) , it is possible that bg-mediated ERK1/2 signaling is not involved in the transmission of signals to the nucleus. However, such a differential role for bg-dynamin-mediated activation of ERK1/2 modules remains to be clarified.
G i stimulation of JNK pathway
In addition to the activation of ERKs, Ga i as well as the bg-associated with Ga i has been shown to activate the JNK module (Coso et al., 1995 Edamatsu et al., 1998; Yamauchi et al., 2000) . Stimulation of ectopically expressed m 2 -muscharinic receptors that couple to G ifamily of G proteins have been shown to activate JNK via bg-subunits in COS-7 cells (Coso et al., 1995 . Similar analysis using mastoparan, which mimics GPCR activation by directly stimulating G proteins (Higashijima et al., 1990) , indicated that JNK could be activated by both the a-and the bg-subunits of G i in HEK293 cells (Yamauchi et al., 2000) . The use of bg-quenching bARK-CT established that the mastoparan activation of JNK involved both Ga i and Gbg i in these cells (Yamauchi et al., 2000) . Consistent with this observation, transient expression of the constitutively activated mutants of Ga i1 , Ga i2 and Ga i3 in HEK293 cells increased JNK activity. Interestingly, similar constitutively activated mutants of Ga o and Ga z , which belong to G i family, failed to stimulate such JNK activation (Yamauchi et al., 2000) . Thus, the activation of JNK appears to be restricted to some G i isoforms but not to other G i family members such as Ga o or Ga z . The expression of dominant negative Rho and Cdc42, but not dominant negative Rac, inhibited Ga i -mediated activation of JNK, suggesting a pathway involving Rho and CDC42 in the activation of JNK by Ga i (Yamauchi et al., 2000) . Interestingly, Ga i -mediated activation of JNK was not inhibited by the dominant negative mutants of MKK4 and MKK7, the upstream MAP2Ks that are typically involved in the activation of JNKs (Yamauchi et al., 2000) . Thus, although, Rho and Cdc42 have been shown to stimulate JNK via MKK4 in HEK293 T cells , Ga i -mediated activation of JNK proceeds through a novel pathway involving Rho and/or CDCD42 and a hitherto uncharacterized tyrosine kinase via an MKK4/7-independent mechanism (Yamauchi et al., 2000) . In contrast, the pathways involving bg-subunit dissociated from Ga i have been demonstrated to involve Ras and Rac . In addition, bg-mediated stimulation of JNK involves both MKK4 and MKK7, as bg-activated JNK can be inhibited by the dominant negative mutants of MKK4 as well as MKK7 (Yamauchi et al., 1999) . Although bg-activation of MKK4 proceeds through Rho and CDC42, its activation of MKK7 involves Rac (Yamauchi et al., 1999) . Although the physiological significance is not known, it has been shown that bg-preferentially activates MKK4 in HEK293 cells.
The signaling network that is being unraveled by these studies indicates that both Ga i and Gbg i activate JNK module via distinct subunit-specific small GTPases (Figure 2 ). However, in both Ga i -and Gbg i -mediated activation of JNK, a tyrosine kinase is involved in the activation of the respective small GTPases (Yamauchi et al., 1999 (Yamauchi et al., , 2000 , presumably involving tyrosine kinase responsive-specific GEFs (Shou et al., 1995; van Biesen et al., 1995; Miyamoto et al., 2003) . Similar to the activation of the ERK module by Gbg i -subunit, the activation of JNK by Gbg i appears to require a PI3K activity in certain cellular contexts, such as the activation of G i -coupled m-opioid receptor (Kam et al., 2004) .
Regulation of MAPKs by G q
The G q family of G proteins is defined by the ubiquitously expressed Ga q , Ga 11 and hematopoetic cell-specific Ga 14 , and Ga 15/16 subunits (Simon et al., 1991; Hubbard and Hepler, 2006) . All of the family members have been shown to activate ERK1/2, JNK and p38MAPK modules. The a-subunits of G q family of G proteins transduce signals from their cognate receptors to specific cellular responses via the activation of the effector PLCb (Johnson and Dhanasekaran, 1989; Simon et al., 1991) . Activated PLCb hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol triphosphate (IP3) and diacylglycerol (DAG), both of which can activate protein kinase C (PKC), either directly or indirectly via the release of internally stored Ca 2 þ . In addition to these a-subunitmediated pathways, the bg-subunit released from G q can also activate PLCb (Camps et al., 1992 : Katz et al., 1992 and transmit signals through both PLC-DAG-PKC-and PLC-IP3-Ca 2 þ -mediated signaling pathways (Figure 3 ).
G q stimulation of ERK1/2
Ga q can stimulate ERK1/2 module via PLC-DAG-PKC as well as PLC-IP3-Ca 2 þ signaling mechanisms. Ga q -activated PKC can stimulate ERK1/2 module by directly phosphorylating and stimulating C-Raf (Kolch et al., 1993; Ueda et al., 1996; Schonwasser et al., 1998 ). An alternate mechanism involving Ca 2 þ -calmodulinmediated activation of Pyk2 leading to the activation of Ras and subsequently ERK1/2 module can also be envisaged (Lev et al., 1995; Dikic et al., 1996; Della Rocca et al., 1997) . However, whether Ga q/11 activates ERK1/2 via the PKC-Raf signaling axis or IP3-Ca 2 þ -calmodulin-Pyk2-Src-Ras pathway appears to be cell type dependent. It has been shown that m 1 -muscarinic receptor-mediated activation of Ga q stimulates the ERK1/2 module via PKC-C-Raf signaling axis in Cos-7 and CHO cells . In contrast, G q -coupled LPA-or bradykinin receptors activate ERK1/2 via calcium-calmodulin-dependent pathway involving Pyk2, Src and Ras . In HEK293 cells, a 1 -adrenergic receptor-mediated activation of ERK1/2 appears to involve PKC-as well as Ca 2 þ -mediated pathways (Della Rocca et al., 1997) . In addition to these typical Ga q -mediated pathways, it has also been shown that Ga q can activate ERK through a novel mechanism involving a DAG-as well as Ca 2 þ -dependent Rap-1-GEF (Guo et al., 2001) . Using a variant of PC12 cells, PC12D, it has been shown that m 1 -muscarinic receptor stimulation of ERK1/2 modules is independent of Ras but dependent on Ga q -stimulated PLCb. More interestingly, it has been shown that G q -mediated release of DAG and Ca 2 þ leads to the activation of a calcium-and diacylglycerol-regulated guanine nucleotide exchange factor, CalDAG-GEFI that can stimulate Rap-1, which in turn, can activate B-Raf and the downstream ERK1/2 module (Guo et al., 2001) . Thus, Ga q -mediated signaling to ERK1/2 module appears to involve three distinct mechanisms: (1) PKC-mediated activation of C-Raf; (2) Ca 2 þ -Pyk2-Src-dependent activation of Ras; and (3) Ca 2 þ -DAG-stimulated Rap1-mediated activation of B-Raf. As Ga q/11 activation results in the generation of both DAG and IP3, all of these mechanisms need not be mutually exclusive. It should be noted here that since bgsubunits disassociated from G q/11 -coupled receptors can also stimulate PLCb, it is possible that they also contribute to G q/11 signaling to ERK1/2 modules in a similar manner. However, it has been noted that G q/11 -coupled receptors primarily use the DAG/ PKC-and/or IP3/Ca 2 þ signaling pathways, rather than bg-subunits, to activate ERK1/2 modules (Blaukat et al., 2000) . A footnote here is that in some cellular contexts, as in the case of the activation of ERK1/2 by G q -coupled oxytocin receptors, the bg-disassociated from G q activates ERK1/2 through the transactivation of receptor tyrosine kinase (Zhong et al., 2003) .
G q stimulation of JNK
In contrast to the major role of the a-subunits of the G q family in activating the ERK module, the a-as well as the bg-subunits of G q plays determinant roles in the activation of JNK module (Coso et al., 1995 Mitchell et al., 1995; Zohn et al., 1995; Nagao et al., 1998) . Receptors that couple to G q such as the m 1 -muscarinic (Coso et al., 1995) , m 3 -muscarinic (Wylie et al., 1999) , angiotensin II (Zohn et al., 1995) , a 1 adrenergic (Ramirez et al., 1997) thrombin (Shapiro et al., 1996) and endothelin-1 (Shapiro et al., 1996) receptors have been shown to potently stimulate the JNK module. The findings that Ga q activates MEKK1 and MEKK1 deficiency disrupts Ga q -mediated activation of JNK suggest that MEKK1 is a primary signaling hub for the activation of JNK by Ga q (Minamino et al., 2002) . However, the molecular mechanism(s) through which G q communicates to the JNK module appears to be cell-type specific. Using ectopic expression of G qcoupled m 1 -muscarinic receptors in NIH3T3 (Coso et al., 1995) , Rat1a (Mitchell et al., 1995) , COS-7 or HEK293 cell (Nagao et al., 1998) , it has been shown that the stimulation of these receptors lead to the potent activation of JNK module. While, G qcoupled m 1 -muscarinic receptor activation of JNK does not involve the PLC-PKC axis in NIH3T3 cells (Coso et al., 1995) , studies with COS-7 cells indicated that the activation of JNK by m 1 -muscarinic receptor involves a pathway initiated by the Gbg q -involving Ras and Rac-1 . In contrast, studies using Rat1a cells have shown that m 1 -muscarinic receptor activation of JNK by Ga q involves a Ca 2 þ -dependent mechanism (Mitchell et al., 1995) , thereby suggesting a role for the Ga q -PLC-IP3 signaling axis. Likewise, it has been shown that Ga q -coupled angiotensin II receptor activation of JNK proceeds through such Ca 2 þ -dependent signaling, possibly involving a PLC-IP3-based mechanism (Zohn et al., 1995) . Interestingly, such Ca 2 þ -dependent signaling has also been shown to be sensitive to genistein, suggesting a role for Ca 2 þ -dependent tyrosine kinase phosphorylation (ibid). In addition, a direct role for PKC in the activation of JNK has also been established. In HEK293 cells, it has been shown that the expression of the constitutively activated mutant of Ga 11 results in the activation of JNK through a pathway involving PKC as well as Src family of tyrosine kinases (Nagao et al., 1998) .
The general mechanism emerging from these studies is that G q can use both the a-as well as bg-subunits involving the PLC-DAG-PKC as well as the PLC-IP3-Ca 2 þ signaling arms to activate JNK. Src-or an Src-like kinase appears to be involved in the activation of JNK in both the pathways (Zohn et al., 1995; Nagao et al., 1998) . Therefore, PKC activation of Src and subsequent Src-mediated activation of Rac through a specific GEF appears to be involved in Ga q -mediated activation of JNK via the pathway involving PKC, Src and Rac . Although such a linear pathway has not been established in a specific single cellular context, the previous findings that PKC can readily activate Src through direct phosphorylation (Gould et al., 1985; Moyers et al., 1993) , Src can activate Racspecific GEFs and such activation of Rac can stimulate the JNK module (Crespo et al., 1996; Michiels et al., 1997) strongly points to such a pathway.
Activation of JNK module by the PLC-IP3-Ca 2 þ arm of Ga q signaling has been shown to involve a Ca 2 þ -dependent activation of Pyk2 Blaukat et al., 1999) , Pyk2-induced activation of Src, Src-mediated phosphorylation of p130CAS and the subsequent association of p130CAS and the adaptor protein CrkII (Blaukat et al., 1999; Kodama et al., 2003) . Interestingly, the p130CAS-CRKII complex has been shown to stimulate the JNK module via Rac-1 (Dolfi et al., 1998; Girardin and Yaniv, 2001 ) presumably through the activation of Rac-1 by the Rac-GEF, DOCK180 (Kiyokawa et al., 1998) or R-Ras by the R-Ras/Rap-1-GEF, C3G (Mochizuki et al., 2000) . Therefore, the signaling from Ga q via PLC-IP3-Ca 2 þ is likely to involve Rac-1-or R-Ras-dependent mechanisms, both of which can lead to the activation of JNK module by stimulating JNK-specific MAP4Ks such as MLK3 Tanaka and Hanafusa, 1998) .
Since bg-subunits can stimulate PLC-b and subsequent IP3-mediated Ca 2 þ release/influx, it should be noted here that the bg-signaling, leading to the activation of JNK via Ras and Rho family of GTPases, involves a pathway similar to the one described for Ga q .
G q stimulation of p38MAPK
Similar to its role in the activation of the JNK module, different G q -coupled receptors have been shown to activate the p38MAPK module (Kramer et al., 1995; Krump et al., 1997; Yamauchi et al., 1997) . Further studies have established that G q can activate p38MAPK module through a-as well as the bg-subunits (Yamauchi et al., 1997 (Yamauchi et al., , 2001 Nagao et al., 1998; Huang et al., 2004) . The basic mechanism through which Ga q activates p38MAPK is not different from the one involved in the activation of the JNK module. The PLC-DAG-PKC signaling arm of Ga q along with the activation of Src or an Src-like tyrosine kinase has been shown to be involved in Ga q -mediated activation of p38MAPK (Nagao et al., 1998; Yamauchi et al., 2001) . Thus, the signaling pathways mediated by Ga q involve PLC-PKC-dependent activation of Src followed by Src activation of the Rho family of GTPases leading to the activation of p38MAPK module. Consistent with this view, it has been shown that Ga q activates MKK3 or MKK6, the MAP2Ks of p38MAPK module, via CDC42, Rac and Rho (Yamauchi et al., 2001) . The observations that the Rac-specific GEFs Tiam-1 and Ras-GRF, both of which can be activated by Src, are in physical complex with MKK3 and p38MAPK (Buchsbaum et al., 2002) provides partial evidence for such a pathway that can be activated by Ga q .
In contrast to the role of PLC-PKC in Ga q -mediated pathways, the bg-pathways derived from the G q heterotrimer involves a PLC-independent mechanism(s) involving Rho family of GTPases and a tyrosine kinase that remains to be identified (Yamauchi et al., 2001 ). In addition, it has been shown that G q -derived bg-subunit can activate p38MAPK via a pathways involving Rap-1 (Huang et al., 2004) . It is quite likely that the activation of Rap-1 by bg-subunits involves a Pyk2-Src-C3G pathway similar to the one involved in the activation of JNK (Mochizuki et al., 2000) . Although the mechanism by which Rap-1 activates p38MAPK module is not fully elucidated, the findings that bg-pathway can stimulate C3G (Mochizuki et al., 2000) , and C3G can stimulate Rap-1 (Gotoh et al., 1995) as well as MLK3/DLK family of kinases (Tanaka and Hanafusa, 1998) and MLK3 can activate p38MAPK (Chadee and Kyriakis, 2004; Kim et al., 2004) points to MLK family of MAP3Ks as a possible link between Rap-1 and p38MAPK modules.
Ga q stimulation of p38MAPKg/ERK6 module p38MAPKg, an isoform of p38MAPK that shows distinct expression and activation profiles, is characterized as ERK6 (Lechner et al., 1996; Kumar et al., 1997; Wang et al., 2000) . Similar to the p38MAPK module, p38MAPKg/ERK6 is activated by the MAP2Ks, MKK3 and MKK6 (Kumar et al., 1997; Wang et al., 2000) . It has also been shown that the small GTPase Rho activates p38MAPKg/ERK6 via its stimulatory interaction with PKN, which can activate the MLK-like kinases that act as MAP3Ks of this module (Wang et (Marinissen et al., 1999) . In analysing the role of PAR-1 receptors in stimulating c-Jun expression and oncogenic transformation, the ability of Ga q to activate p38MAPKg/ERK6 was characterized. It appears that the activation of ERK6 is mediated primarily by the a-subunit rather than the bg-subunit . Since Ga q can stimulate Rho-GEF proteins such as leukemiaassociated Rho-GEF (LARG) (Booden et al., 2002) , it is very likely that Ga q -mediated activation of the p38MAPg/ERK6 module involves Rho-dependent activation of PKN and subsequent stimulation of MLK-family of MAP3Ks followed by MKK3/6 and p38MAPKg/ERK6 (Wang et al., 2000; Marinissen et al., 2001 Marinissen et al., , 2003 Gross et al., 2002; Takahashi et al., 2003) . In this context, it should be noted that since p38MAPKg/ ERK6 is activated by MKK3 and MKK6, which are also involved in the activation of other p38MAPK-isoforms, it could also be regulated by the mechanisms outlined in the previous section.
G q stimulation of ERK5 G q -mediated signaling has also been shown to regulate the ERK-5 module via MEK5 (Marinissen et al., 1999) . Studies using the transient expression of G q -coupled muscarinic receptors have identified that the G qmediated signaling pathway is involved in the regulation of the MEK5-ERK-5 signaling module and subsequent transactivation of c-Jun via MEF2 family of transcription factors (Marinissen et al., 1999) . Further studies using a chimeric mutant of Ga q and Ga i , through which Ga q -mediated signaling can be activated by Ga i -coupled muscarinic receptors, have established that Ga q and not Gbg q is involved in the activation of ERK5 (Fukuhara et al., 2000b) . Although the mechanism by which Ga q is coupled to the MEK5-ERK5 module is not fully understood, initial studies have identified that it is not through Ras, CDC42, Rac or Rho (Fukuhara et al., 2000b) . However, the observation that the MAP3Ks MEKK2 and MEKK3 can interact and activate MEK5 (Sun et al., 2001) suggests the possible role of these MAP3Ks in this pathway. In conjunction with the findings that Rap-1 is involved in the activation of ERK5 via MEKK2 (Wang et al., 2006a) and G q can activate Rap-1 via the Rap-1-GEF CG3 or CalDAG-GEFI as discussed in the previous sections, it is likely that Ga q , via Rap-1, activates the MEKK2-MEK5-ERK5 module. However, these earlier events involved in Ga q -mediated activation of ERK5 remain to be established.
Regulation of MAPKs by G 12
The G 12 family of G proteins, defined by the a-subunits Ga 12 and Ga 13 , is extremely potent in inducing neoplastic transformation of fibroblast cell lines (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994; Dhanasekaran and Dermott, 1996; Liu et al., 1997) . In view of the findings that constitutively active Ga 12 was isolated as the transforming 'oncogene' from the Ewings sarcoma cell line (Chan et al., 1993) and that Ga 12 potently stimulates the neoplastic transformation of fibroblast cell lines (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; VoynoYasenetskaya et al., 1994) , it has been designated as 'gep' oncogene Gutkind et al., 1998) . In addition, the expression of these a-subunits has been shown to stimulate mitogenic responses in many different cell lines (Aragay et al., 1995; Denis-Henriot et al., 1998; Coffield et al., 2004) . Further analyses have revealed that these a-subunits can regulate cell proliferation (Aragay et al., 1995; Denis-Henriot et al., 1998; Radhika and Dhanasekaran, 2001; Coffield et al., 2004; Kumar et al., 2006) , differentiation , apoptosis (Althoefer et al., 1997; Berestetskaya et al., 1998) , as well as cell migration (Offermanns et al., 1997; Radhika et al., 2004; Dhanasekaran, 2006; Shan et al., 2006) in a context-specific manner. A search for the underlying signaling mechanism(s) identified that G 12 proteins strongly stimulate JNK activity in a variety of cells (Prasad et al., 1995; Collins et al., 1996; VoynoYasenetskaya et al., 1996; Nagao et al., 1999; Arai et al., 2003; Marinissen et al., 2003) , and the inhibition of which could abrogate Ga 12/13 -mediated G1 to S phase cell cycle progression (Mitsui et al., 1997) .
G 12/13 signaling to JNK module Having 67% shared amino acid identity, Ga 12 and Ga 13 stimulate similar responses including the activation of JNK in many cellular contexts (Radhika and Dhanasekaran, 2001 ). However, the mechanism through which these a-subunits couple to the JNK module appears to be cell-type or physiological context dependent. In these different contexts, Ga 12 and Ga 13 activate the JNK module via the small GTPases Ras, CDC42, Rac or Rho (Figure 4) . Although the activated mutant of Ga 12 stimulates JNK via Ras in NIH3T3 cells, it involves Rac1 in 1321N astrocytoma and HEK293 cells (Collins et al., 1996) . In Cos-7 cells, it has been shown to involve CDC42 (Voyno-Yasenetskaya et al., 1996) . All of these small GTPases appear to transmit signals to the JNK module via MEKK1, as the expression of dominant negative MEKK1 has been shown to inhibit Ga 12 -mediated activation of JNK in all of these instances (Collins et al., 1996; Voyno-Yasenetskaya et al., 1996) . Thus, Ga 12 as well as Ga 13 communicates to MEKK1, the upstream MAP3K of the module, via the Ras-or Rho family of small GTPases, presumably through specific GEFs. The identity of the specific GEFs that couple Ga 12 or Ga 13 to JNK module has been identified only in a few instances .
In the case of the Ras-GEF linking Ga 12 to Ras, it appears to involve Shc-mediated recruitment of SOS (Collins et al., 1997) . It has been shown that Ga 12 stimulates Shc-phosphorylation in 1321N1 cells, in which it stimulates JNK via Ras-dependent mechanism (Collins et al., 1996 (Collins et al., , 1997 . Therefore, it has been suggested that Shc-Grb2-recruited SOS is involved in stimulating Ras and subsequently JNK in these cells (Collins et al., 1997) . Although the kinase involved in stimulating the phosphorylation of Shc has not been identified, considering the findings that Ga 12 can stimulate several tyrosine kinases such as Src (Nagao et al., 1999) , Fak (Needham and Rozengurt, 1998; Chikumi et al., 2002) and Tec family of kinases (Mao et al., 1998; Jiang et al., 1998) , it possible that one of these kinases may be involved in stimulating the phosphorylation of Shc. In this context, the observations that Ga 12 can stimulate BTK, a member of Tec family of kinases and BTK can activate JNK via Shc-Grb2-mediated activation of Ras (Deng et al., 1998) , make BTK or one of its family members an attractive candidate in this pathway. The identities of the GEFs that link Ga 12/13 to downstream Rac and CD42 are largely unknown.
In addition to Ras, Rac and CDC42, it has also been shown that Ga 12 stimulates JNK via RhoA (Nagao et al., 1999; Arai et al., 2003) . In HEK293 cells, it has also been shown that Src-dependent stimulation of RhoA is involved in Ga 12 -mediated activation of JNK (Nagao et al., 1999) . The findings that inhibition of Src by treating the cells with PP2 or expressing the dominant negative mutant of Src abrogated the ability of Ga 12 to stimulate such activation suggested that an Src-mediated GEF activity is involved in linking Ga 12 to Rho-mediated activation of JNK module (Nagao et al., 1999) . Although the mechanism by which Ga 12 signals to Src is not fully understood, the ability of Ga 12 to stimulate the GEF activity of tyrosine-phosphorylated LARG is quite significant (Fukuhara et al., 2000a; Suzuki et al., 2003) . LARG may thus be a candidate Rho-GEF involved in linking Ga 12 to Rho in an Srcdependent manner and subsequent activation of JNK module. However, it is also possible that Ga 12 stimulates Rho-mediated activation of JNK module via other Srcresponsive Rho-GEFs. In the case of Ga 13 , it has been shown that it can physically interact with p115RhoGEF and stimulate its GEF activity toward RhoA (Hart et al., 1998) . Consistent with this observation, Rhodependent activation of JNK has been shown to involve p115RhoGEF in P19 cells . Notwithstanding the small GTPase utilized, the MAP3K involved in Ga 12/13 -mediated signaling appears to involve MEKK1 (Collins et al., 1996; Voyno-Yasenetskaya et al., 1996; Wang et al., 2002) . In some contexts, the JNK module activated by Ga 12/13 involves ASK1 (Berestetskaya et al., 1998) , MEKK-2 or MEKK4 as well (Wang et al., 2002; Lee et al., 2004) . Generally, the MAP3Ks activate MKK4 as well as MKK7, the JNKspecific MAP2Ks. However, it has been observed that Ga 12 -mediated activation of JNK preferentially involves MKK7 (Dermott et al., 2004) , whereas Ga 13 -as well as bg-mediated activation appears to involve MKK4 (Yamauchi et al., 1999; Wang et al., 2002; Lee et al., 2004) . Although, the functional significance of these differential preferences for specific MKKs is largely not known, it should be noted here that the dual specificity kinases MKK4 and MKK7 activate JNK by phosphorylating two different amino acid residues. MKK4 has been shown to preferentially phosphorylate Tyr185, whereas MKK7 phosphorylates Thr187 of JNK1 (Fleming et al., 2000) . It has been proposed that both MKK4 and MKK7 are required for the maximal activation of JNK1 (Yang et al., 1997; Lawler et al., 1998; Lisnock et al., 2000) . Since Ga 12 appears to preferentially stimulate MKK7 (Dermott et al., 2004) , whereas Ga 13 stimulates MKK4 (Wang et al., 2002; Lee et al., 2004) , it is likely that the Ga 12 -and Ga 13 -mediated 
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Figure 4 G 12/13 regulation of MAPK networks. Ga 12 as well as Ga 13 can potently activate JNK module by stimulating Ras as well as Rho family of GTPases. In some cells, Ga 12/13 can weakly stimulate ERK1/2 in a Ras-dependent manner, whereas in others they attenuate ERK1/2 activation at the levels of MEKs. In addition, both Ga 12 and Ga 13 can activate ERK5 through hitherto uncharacterized mechanism. In addition, Ga 12 and Ga 13 can regulate different MAPKs through pathways unique to them (dashed lines). While Ga 12 inhibits p38MAPKs in some cell types at the levels of MKKs, Ga 13 stimulates p38MAPKs including p38MAPKg/ ERK6 via MKK3/6 in some cells.
response requires only a partial activation of JNK from the respective MAP2K signaling nodes. It is likely that such partial activation of JNK along with other signaling inputs, such as the activation of ERK module and attenuation of p38MAPK module, are prerequisites for Ga 12 -mediated cell proliferation of NIH3T3 cells or Ga 13 -mediated P19 cell differentiation in which the differential recruitment of MAP2Ks have been observed (Dermott et al., 2004; Wang et al., 2002; Lee et al., 2004) .
Ga 12/13 attenuation of ERK1/2 In contrast to their potent activation of the JNK module, Ga 12 and Ga 13 attenuate the activation of ERK1/2 module in a cell-type-dependent manner (Voyno-Yasenetskaya et al., 1996) . Ras-mediated albeit weaker stimulation of ERK1/2 has been shown to be critically required -along with Ras-/Rac-mediated potent stimulation of JNK activity -for Ga 12 -induced G1-S phase cell cycle progression of NIH3T3 cells (Mitsui et al., 1997) . However, the ectopic expression of Ga 12/13 stimulated JNK activity with a concomitant inhibition of ERK1/2 pathway (Voyno-Yasenetskaya et al., 1996) . Further analysis has identified MEK as the locus at which Ga 12/13 exerts its inhibitory effects on ERK module. Although the underlying mechanism as well as the physiological significance of such regulation is not fully known, recent studies have demonstrated that Ga 12/13 can interact with PP5 to stimulate its activity (Yamaguchi et al., 2002) and PP5 is involved in the downregulation of ERK module by dephosphorylating Raf-1 at Ser-338 (von Kriegsheim et al., 2006) . Therefore, although it remains to be established, it is possible that Ga 12/13 -mediated activation of PP5 is involved in the inhibition of ERK1/2 modules.
Inhibition of p38MAPK by Ga 12
The expression of Ga 12 has also been shown to attenuate the activation of the p38MAPK module (Dermott et al., 2004) . The inhibition was found to be at the level of the three MAP2Ks involved in the activation of p38MAPK, namely MKK4, MKK3 and MKK6. It is interesting that Ga 12 stimulates JNK-specific MKK7 while inhibiting MKK4, which is common to both JNK and p38MAPK. Thus, Ga 12 appears to block decisively all the possible signaling routes that lead to the activation of p38MAPK. However, it should be noted here that the inhibition of p38MAPK appears to be specific for Ga 12 as the expression of Ga 13 in NIH3T3 cells stimulates both JNK as well as p38MAPK activities . Although the molecular basis for such selective inhibition of an MAPK at the levels of multiple MAP2Ks by distinct a-subunits of the G 12 family is not clear at present, at least two possible mechanisms can be speculated: one involving the inhibition of p38MAPK-specific MKKs, presumably through the activation of a specific phosphatase, and the other involving a specific scaffolding protein that distinctly couples Ga 12 to the MKK7-JNK module, while attenuating the MKK3/6/4-p38MAPK module. Since Ga 12 has been shown to directly stimulate phosphatase PP5 (Yamaguchi et al., 2002) as well as PP2A (Zhu et al., 2004) , it is likely that either or both of these phosphatases play a role in attenuating p38MAPK module. However, such a role for these proteins in Ga 12 -mediated attenuation of p38MAPK module remains to be clarified. Likewise, whether the downregulation of p38MAPK by Ga 12 is seen in other cell types remain to be established. However, such differential regulation of JNK and p38MAPK modules is likely to have a significant role in the potent mitogenic activity of Ga 12 seen in diverse cell types (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994; Aragay et al., 1995; Dhanasekaran and Dermott, 1996; Liu et al., 1997; Denis-Henriot et al., 1998; Coffield et al., 2004) . It is likely that the weak stimulation of ERK activity and the decisive downregulation of p38MAPK in addition to the potent stimulation of JNK module provide the multiple signaling inputs required for Ga 12 -mediated cell proliferation.
Ga 13 stimulation of p38MAPg/ERK6
In contrast to Ga 12 , but similar to Ga q , Ga 13 has been shown to stimulate the p38MAPKg/ERK6 module . Considering the inhibitory effect of Ga 12 on MKK3/MKK6, it is more likely that Ga 12 exerts similar attenuation of p38MAPKg/ERK6, at least in fibroblasts such as NIH3T3 cells. However, the transient expression of Ga 13 has been shown to stimulate p38MAPKg/ERK6 activity in NIH3T3 as well as HEK293 cells. It has been suggested that ERK6 stimulation of ATF2 and MEF2 is required for the complete transactivation of c-Jun and the resulting cellular transformation mediated by Ga 13 -coupled PAR-1 receptors . It has been identified that Rho is involved in the upstream stimulation of the ERK6 module via PKN family of protein kinases (Marinissen et al., 2001 . As Ga 13 can stimulate Rho via different GEFs, the mechanism by which Ga 13 transmits signals to p38MAPKg/ERK6 is likely to involve Rho and Rho-activated PKN. Since the MAP3Ks such as MLK-like MAP triple kinase or MLK-related kinase (Gross et al., 2002) can regulate ERK6 via MKK3/6 (Wang et al., 2000; Marinissen et al., 2001 Marinissen et al., , 2003 Gross et al., 2002; Takahashi et al., 2003) , it is likely that Ga 13 -activation involves a phospho-relay module involving these upstream kinases.
Ga 12/13 stimulation of ERK5 In analysing the mechanism by which PAR-1 receptors, which can couple to both G q and G 12 -family of G proteins, activate ERK5, it was identified that the a-subunits of G 12 as well as G 13 are involved in the regulation of ERK5. Since activation of ERK5 by constitutively active Ga 12 and Ga 13 was insensitive to the coexpression of the dominant negative mutants of Ras, CDC42, Rac or Rho, the activation appears to involve an alternate GTPase or mechanism (Fukuhara et al., 2000b) . An attractive candidate is Rap-1, which can stimulate MEKK2 and hence the MEKK2-MEK5-ERK5 module (Wang et al., 2006a) . However this possibility as well as the mechanism by which Ga 12/13 communicates to Rap-1 needs to be experimentally verified.
Receptor tyrosine kinases in G-protein-mediated activation of MAPKs
In addition to the signaling pathways leading to the regulation of MAPK modules by different G proteins, GPCRs have been shown to regulate ERK1/2 modules through the transactivation of RTKs. Such a novel role for EGFR in the activation of ERK by GPCRs was identified with the observation that the stimulation of Rat1a cells with GPCR agonists including endothelin, LPA and thrombin stimulated the phosphorylation of EGFR and Her2 along with the activation of ERK2 (Daub et al., 1996) . The findings that the treatment of these cells with the EGFR inhibitor tyrphostin AG1478 or the expression of a dominant negative EGFR mutant inhibited such ERK activation indicated the critical role of EGFR in the activation of ERK by GPCRs (Daub et al., 1996) . Further analyses revealed that EGFR plays a determinant role in GPCR-mediated activation of the ERK module in a variety of cell types Zwick et al., 1997; Eguchi et al., 1998) . Primarily, G iand G q -coupled receptors transactivate EGFR through a novel mechanism involving 'ecto-domain shedding' and subsequent generation of soluble EGF-like growth factors that can stimulate EGFRs (Prenzel et al., 1999) . Recently, the molecular basis for GPCR-mediated transactivation of EGFR has been summarized (Ohtsu et al., 2006) . The transactivation of EGFR by GPCRs involves both intracellular as well as extracellular mechanisms. Thus, EGFR transactivation by G i -or G q -coupled receptors has been shown to require the intracellular generation of Ca 2 þ (Zwick et al., 1997; Eguchi et al., 1998; Murasawa et al., 1998; Soltoff, 1998; Iwasaki et al., 1999) , and activation of PKC, Src and Pyk2 (Gschwind et al., 2001) . These pathways appear to converge on the activation of a family of a disintegrin and metalloprotease (ADAM) and/or matrix metalloprotease (MMP) proteins through phosphorylation as well as protein-protein interactions (Higashiyama and Nanba, 2005; Ohtsu et al., 2006) . The activated single transmembrane ADAMs, specifically ADAM-10, -12, -15, -17, cleave the ectodomains of membrane-bound EGFR ligands such as HB-EGF to generate soluble EGF ligands that can activate EGFRs (Gschwind et al., 2001; Schafer et al., 2004; Higashiyama and Nanba, 2005; Ohtsu et al., 2006) .
Although these studies have shown the role of EGFR in G-protein signaling, it has also been shown that signaling by RTKs to the ERK module can be enhanced by G proteins through a mechanism involving b-arrestin. For example, it has been shown that the activation of the ERK module by RTK ligands involves a G-protein-independent as well as G-protein-dependent pathways (Conway et al., 1999) . In the G-protein independent, classical pathway, signaling to ERK involves PDGF-activated PDGFR autophosphorylation on tyrosine residues, recruitment of adaptor proteins and activation of p42/p44 MAPK. However, the G-protein-dependent pathway appears to involve G i and b-arrestin-mediated endocytosis. In this pathway, endocytitic internalization of G i -activated GPCRs along with G i -activated c-Src, PDGFR, ERK module and Grb-2 is facilitated by arrestin and dynamin II. It has been speculated that the close proximity and the possible activation of Raf-1 by Src promotes the activation of ERK module in endosomes (Waters et al., 2005) . Further studies should define the role of such networking between RTKs and G proteins in specific cellular responses.
Scaffold proteins in G-protein signaling to MAPKs
As discussed in previous sections, diverse GPCRs, through the a-as well as the bg-subunits of the four classes of G proteins, modulate the activities of different MAPK modules. Interestingly, as can be seen in the case of PAR-or thrombin receptors, a specific GPCR may recruit a-or bg-subunits from different classes of G proteins to activate an MAPK module in a cell type-or context-specific manner. Even the individual a-or bgsubunit may activate a specific MAPK module through more than one mechanism in a context-specific manner. In addition, the signaling molecules providing these mechanisms such as the small GTPase, their cognate GEFs, and the downstream kinases, are often shared by different Ga-or bg-subunits activating distinct MAPK modules. So the major question is how do these distinct pathways from different G proteins elicit distinct functional responses involving specific MAPKs with little or no signaling crosstalk with each other. Although studies from yeast have pointed out that specific scaffold proteins such as Ste5 can facilitate such context-specific linking of G-protein signaling to downstream MAPK modules (Herskowitz, 1995; Elion, 2001; Elion et al., 2005) , the evidence for such scaffold proteins in mammalian G-protein signaling to MAPKs emerged only recently. Of these scaffold proteins, some of them such as the b-arrestins play a catalytic as well as anchoring role in linking different GPCRs to MAPK signaling, whereas others such as MAP kinase organizer (MORG) and JLP play an anchoring role by tethering specific G proteins and MAPK modules in a contextspecific manner (Garrington and Johnson, 1999; Morrison and Davis, 2003; Kolch, 2005) .
Catalytic role of b-arrestin in GPCR signaling to ERKs
The arrestin family of proteins was initially identified to be involved in the desensitization of GPCRs by facilitating their internalization (Freedman and Lefkowitz, 1996; Kohout and Lefkowitz, 2003) . Signaling by agonist-activated GPCRs is terminated by the GRK-family of serine/threonine kinases that phosphorylate the receptors at their C-termini (Freedman and Lefkowitz, 1996) . b-arrestins bind to such phosphorylated receptors and facilitate their internalization by endocytosis via clathrin-coated pits (Shenoy and Lefkowitz, 2003) . Interestingly, it has been shown that b-arrestin-1 can bind to both GRK-phosphorylated receptors, such b2-AR, as well as c-Src, targeting them to clathrin-coated pits where the complex acts as signaling hub for the activation of ERK1 and ERK2 (Luttrell et al., 1999) . In addition, it has been shown that b-arrestin-2 can sequester components of the ERK module such as Raf-1, MEK1/2 and ERK1/2 via its interaction with Raf-1 (Luttrell et al., 2001) . The barrestin scaffold containing the components of the ERK module and the receptor are internalized via clathrincoated pits into endosomal vesicles where the receptor can activate the ERK module (Lefkowitz and Shenoy, 2005) . Although the mechanism by which the internalized GPCR can activate the ERK module is yet to be elucidated fully, it is possible that the other co-internalized intermediary molecules such as Src play a role in providing such a link. Interestingly, it has been noted that the ERK module activated by b-arrestin has slower kinetics of activation than that mediated by G proteins (Lefkowitz and Shenoy, 2005) . In addition, it has been observed that the ERK module activated by b-arrestin is not involved in nuclear signaling (DeFea et al., 2000; Tohgo et al., 2002) . Thus, b-arrerestin-2-mediated activation of ERK module by different GPCRs appears to be involved in the cytosolic responses that require slower but persistent activation of ERKs (DeFea et al., 2000; Tohgo et al., 2002; Lefkowitz and Shenoy, 2005) .
In addition to the activation of the ERK module, b-arrestin-2 also appears to be involved in regulating the JNK module. Using yeast two hybrid screening, it was identified that b-arrestin-2 can interact with JNK3 (McDonald et al., 2000) . Further analyses indicated that b-arrestin-2 interacts with the MAP3K, ASK1. In addition, MKK-4 also can be colocalized along with b-arrestin, ASK1 and JNK3 in a complex. It has also been observed that angiotensin II type IA receptor stimulated the colocalization of b-arrestin-2 and JNK3 to intracellular vesicles along with the activation of JNK3 (McDonald et al., 2000) . However, it is not clear whether b-arrestin plays a catalytic role in stimulating JNK3 in this context.
Role of MORG-1 in linking GPCRs to ERK1/2 pathway MORG-1 was identified as a 35 kDa protein that interacts with MEK-partner 1 proteins in a yeast two hybrid screen (Vomastek et al., 2004) . Further characterization of this WD-40 motif containing protein indicated that it can associate with Raf-1, B-Raf, MEK1, MEK2, ERK1 and ERK2. Although the ectopic expression of MORG1 enhanced LPA or PMAmediated activation of ERK, it failed to have such stimulatory effects on PDGFR-or EGFR-mediated activation of ERK. In addition, although silencing MORG-1 suppressed ERK-1 activation by FBS (which contains several ligands including LPA that can activate the respective GPCRs), it did not have any effect on EGF-stimulated ERK response. Thus, MORG-1 that can associate with the MAP3K, MAP2K, as well as the MAPK components of ERK1/2 module, appears to provide a scaffolding function specifically for GPCRs such as LPA receptors. At present, it is not known whether such a role of MORG1 involves its physical interaction with specific GPCRs, Ga-or Gbg-subunits. Further studies should define the molecular mechanism by which MORG-1 links GPCR signaling to ERK1/2.
Role of JLP in linking Ga 12/13 to JNK module JLP was initially identified as a Leucine Zipper domain containing protein that can interact with Max (Lee et al., 2002) . In addition, it has been observed that JLP can interact with JNK, p38MAPK, MKK4 and MEKK3. Furthermore, it was observed that the expression of JLP potentiated cytotoxic stress-mediated activation of JNK (Lee et al., 2002) . Recent studies have shown that JLP can interact with Ga 12 as well as Ga 13 and provide a scaffolding role for JNK activation by these a-subunits (Kashef et al., 2005) . It has been demonstrated that JLP interacts with the a-subunits of the G 12 family through the C-terminal region of JLP, spanning amino acids 1165-1307. Using the expression of this Ga 12/13 interacting domain or siRNA-mediated silencing of JLP, it was demonstrated that the disruption of the JLP-Ga 13 interaction leads to the attenuation of LPA-as well as Ga 13 -mediated activation of JNK. Furthermore, it has been observed that silencing JLP inhibits retinoic acid-mediated endodermal differentiation of P19 cells (Kashef et al., 2006) , which is critically dependent on Ga 13 -mediated activation of JNK Wang et al., 2002; Lee et al., 2004) . In this context, it is significant to note that JLP is the first known mammalian scaffold protein, albeit similar to Ste5, in tethering all the signaling components from the proximal Ga-subunit to the downstream MAPK. Since the Ga 12/13 -interacting C-terminus of JLP is conserved among all the JIP family of scaffold proteins, it is possible that JIPs may also be involved in linking Ga 12/ 13 or other a-subunits to JNK or p38MAPK modules in a context-specific manner. This, as well as other finer details of the JLP scaffold, such as its interactions with specific small GTPases and their GEFs, remains to be established. Similarly, further studies should define the role of such scaffold proteins in Ga-or Gbg-mediated activation of other MAPK modules.
Conclusion
Recent studies have contributed to a greater understanding of the mechanisms by which the GPCR family of cell surface receptors critically regulate different aspects of cell growth via the MAPK signaling modules. As the signaling nexus between different G proteins and distinct MAPK modules are being realized, the pathophysiological roles of aberrant-or asynchronous signaling by these pathways are becoming increasingly clear. However, as presented in this review, several aspects of these pathways involved in G-proteinmediated MAPK activation remain to be resolved. For example, the molecular basis for context-specific signaling, the spatio-temporal organization of G-protein-MAPK signaling complexes, the effects of these pathways in relation to receptor tyrosine kinase-or cytokine receptor-mediated activation of MAPKs, and most importantly, the potential role of G-protein-regulated MAPK networks in tumorigenesis and progression remain to be fully characterized. A case to the point is the identification of the potential role of LPA-and PAR-receptor-mediated signaling pathways in the genesis and progression of ovarian, breast and prostate cancers (Mills and Moolenaar, 2003; Booden et al., 2004; Daaka, 2004; Boire et al., 2005) . The findings that all of these GPCRs, their cognate G proteins and the Gprotein oncogenes gsp, gip2 and gep converge on the activation of distinct MAPK modules, taken together with the observation that GPCR-mediated signaling pathways are well-validated drug targets, underscore the critical need for defining these pathways further so that better therapeutic targets can be identified.
